No Data
No Data
No Data
No Data
No Data
TikTok to Restrict Weight Loss Drug Promotion
Popular social media platform TikTok is cracking down on most content related to weight loss drugs starting next month, according to the video-sharing site's new community guidelines published last week.
Seeking AlphaApr 23 11:26 ET
More contests are coming! Global Data: 13 new weight loss drugs are expected to be launched by 2029
Pharmacists are preparing to launch around 13 new weight loss treatments in the US within the next five years due to a surge in demand for weight loss products, according to a new report from global data analysis and consulting firm Global Data.
Zhitong FinanceApr 22 03:29 ET
13 New Obesity Drugs Could Hit the Market by 2029 Amid Surging Demand
Drugmakers are preparing to launch an estimated 13 new weight-loss treatments in the U.S. over the next five years amid surging demand for the products, according to a new report by Global Data.
Seeking AlphaApr 21 20:04 ET
How Is The Market Feeling About Altimmune?
Altimmune's (NYSE:ALT) short percent of float has risen 15.72% since its last report. The company recently reported that it has 12.51 million shares sold short, which is 17.81% of all regular shares t
BenzingaApr 8 09:00 ET
If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today
Altimmune (NASDAQ:ALT) has outperformed the market over the past 5 years by 11.42% on an annualized basis producing an average annual return of 23.99%. Currently, Altimmune has a market capitalization
BenzingaApr 3 16:31 ET
Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Terns Pharmaceuticals (TERN) and Altimmune (ALT)
TipRanksApr 3 08:11 ET
Mynor Garcia : Hey man a win is a win don't have any regrets about it. It'll start to cloud your judgement. Be happy, Thank God and move along.
Kevin Lehmann : going to jump
Kevin Lehmann : just started
Kevin Lehmann : ask increased
Kevin Lehmann : needs a bit more to turn green
Kevin Lehmann : jump time
Kevin Lehmann : just started
Kevin Lehmann : ask increasing
Kevin Lehmann : it turned green now
104714243 : it will dip and bounce back. they are still in growth mode for this so once it flies then great. buy buy buy
104714243 104714243: it's coming back. the actual.produxt results are great just bad earnings but this is superb news in their trials.
Kevin Lehmann : look at proposial lines
No Data
No Data
104714243OP : Great assessment of this awesome potential